| dbo:abstract |
Seratrodast (development name, AA-2414; marketed originally as Bronica) is a thromboxane A2 (TXA2) receptor (TP receptor) antagonist used primarily in the treatment of asthma. It was the first TP receptor antagonist that was developed as an anti-asthmatic drug and received marketing approval in Japan in 1997. As of 2017 seratrodast was marketed as Bronica in Japan, and as Changnuo, Mai Xu Jia, Quan Kang Nuo in China. Unlike thromboxane synthase inhibitors such as ozagrel, seratrodast does not affect thrombus formation, time to occlusion and bleeding time. Seratrodast has no effect on prothrombin time and activated partial thromboplastin time, thus ruling out any action on blood coagulation cascade. (en) Seratrodast (łac. seratrodastum) – wielofunkcyjny organiczny związek chemiczny, pochodna 1,4-benzochinonu, agonista receptora tromboksanu A2 (TXA2), stosowany jako lek w astmie oskrzelowej. (pl) |
| dbo:alternativeName |
. (en) Bronica in Japan, Changnuo, Mai Xu Jia, Quan Kang Nuo in China and as Seradair in India. (en) |
| dbo:casNumber |
112665-43-7 |
| dbo:fdaUniiCode |
4U58JM421N |
| dbo:kegg |
D01123 |
| dbo:pubchem |
2449 |
| dbo:thumbnail |
wiki-commons:Special:FilePath/Seratrodast.svg?width=300 |
| dbo:wikiPageID |
18460129 (xsd:integer) |
| dbo:wikiPageLength |
11143 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1009170743 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbr:Elevated_transaminases dbr:Blood_coagulation dbr:Airway_hyper-responsiveness dbc:1,4-Benzoquinones dbc:Carboxylic_acids dbr:Oral_administration dbr:Emphysema dbr:Receptor_antagonist dbr:Prothrombin_time dbr:Bronchitis dbr:Thromboxane_A2 dbr:Allergic_rhinitis dbr:Bronchoconstriction dbr:Ozagrel dbr:Paracetamol dbr:Thrombus dbr:Aspirin dbr:Asthma dbr:Bleeding_time dbr:Tablet_(pharmacy) dbr:Pimelic_acid dbr:Cephem dbr:Vasoconstriction dbr:Thromboxane_receptor dbr:Activated_partial_thromboplastin_time dbr:Thromboxane_receptor_antagonist dbr:Thromboxane_synthase dbr:Mucous dbr:File:Seratrodast_synth.png |
| dbp:atcPrefix |
R03 (en) |
| dbp:atcSuffix |
DX06 (en) |
| dbp:c |
22 (xsd:integer) |
| dbp:casNumber |
112665 (xsd:integer) |
| dbp:chemspiderid |
2355 (xsd:integer) |
| dbp:eliminationHalfLife |
79200.0 |
| dbp:h |
26 (xsd:integer) |
| dbp:iupacName |
7 (xsd:integer) |
| dbp:kegg |
D01123 (en) |
| dbp:legalStatus |
Rx-only (en) |
| dbp:o |
4 (xsd:integer) |
| dbp:proteinBound |
>96% (en) |
| dbp:pubchem |
2449 (xsd:integer) |
| dbp:routesOfAdministration |
By mouth (en) |
| dbp:smiles |
CC1=CC (en) |
| dbp:stdinchi |
1 (xsd:integer) |
| dbp:stdinchikey |
ZBVKEHDGYSLCCC-UHFFFAOYSA-N (en) |
| dbp:tradename |
Bronica in Japan, Changnuo, Mai Xu Jia, Quan Kang Nuo in China and as Seradair in India. . (en) |
| dbp:unii |
4 (xsd:integer) |
| dbp:verifiedfields |
changed (en) |
| dbp:verifiedrevid |
443303926 (xsd:integer) |
| dbp:watchedfields |
changed (en) |
| dbp:wikiPageUsesTemplate |
dbt:Drugbox dbt:Prostanoidergics dbt:Reflist dbt:Short_description dbt:Cascite dbt:Chemspidercite dbt:Drugbankcite dbt:Fdacite dbt:Keggcite dbt:Stdinchicite dbt:Asthma_and_copd_rx dbt:Drugs.com |
| dcterms:subject |
dbc:1,4-Benzoquinones dbc:Carboxylic_acids |
| gold:hypernym |
dbr:Thromboxane |
| rdf:type |
owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:WikicatBenzoquinones yago:Abstraction100002137 yago:Chemical114806838 yago:Compound114818238 yago:Material114580897 yago:Matter100020827 yago:Part113809207 yago:PhysicalEntity100001930 yago:Quinone115000973 yago:Relation100031921 dbo:Drug yago:Substance100019613 |
| rdfs:comment |
Seratrodast (łac. seratrodastum) – wielofunkcyjny organiczny związek chemiczny, pochodna 1,4-benzochinonu, agonista receptora tromboksanu A2 (TXA2), stosowany jako lek w astmie oskrzelowej. (pl) Seratrodast (development name, AA-2414; marketed originally as Bronica) is a thromboxane A2 (TXA2) receptor (TP receptor) antagonist used primarily in the treatment of asthma. It was the first TP receptor antagonist that was developed as an anti-asthmatic drug and received marketing approval in Japan in 1997. As of 2017 seratrodast was marketed as Bronica in Japan, and as Changnuo, Mai Xu Jia, Quan Kang Nuo in China. (en) |
| rdfs:label |
Seratrodast (pl) Seratrodast (en) |
| owl:sameAs |
freebase:Seratrodast yago-res:Seratrodast wikidata:Seratrodast dbpedia-pl:Seratrodast dbpedia-sh:Seratrodast dbpedia-sr:Seratrodast dbpedia-vi:Seratrodast https://global.dbpedia.org/id/4v9uE |
| prov:wasDerivedFrom |
wikipedia-en:Seratrodast?oldid=1009170743&ns=0 |
| foaf:depiction |
wiki-commons:Special:FilePath/Seratrodast.svg wiki-commons:Special:FilePath/Seratrodast_synth.png |
| foaf:isPrimaryTopicOf |
wikipedia-en:Seratrodast |
| is dbo:wikiPageRedirects of |
dbr:ATC_code_R03DX06 dbr:ATCvet_code_QR03DX06 |
| is dbo:wikiPageWikiLink of |
dbr:Drug_nomenclature dbr:ATC_code_R03DX06 dbr:ATCvet_code_QR03DX06 dbr:ATC_code_R03 dbr:C22H26O4 dbr:Thromboxane_receptor dbr:List_of_drugs:_Se–Sh |
| is foaf:primaryTopic of |
wikipedia-en:Seratrodast |
